Cardiothoracic & vascular anesthesia

Efficacy of maintaining low-tidal volume mechanical ventilation as compared to resting lung strategy during coronary artery bypass graft cardiopulmonary bypass surgery: A post-hoc analysis of the MECANO trial

J Clin AnesthPublished Secondary analysis of the MECANO randomised trial

Primary resultResult — go to the resultOdds ratio 0.56 CI 0.37–0.84

Authors' conclusion

In this post-hoc analysis, maintaining low-tidal ventilation compared to a resting-lung strategy was associated with fewer pulmonary postoperative complications in patients who underwent isolated CABG procedures.

Study context

Population
Patients undergoing isolated on-pump CABG surgery, tertiary care cardiac surgery centerfrom 1501 in original trial
Participants
725 patients
Comparison
Low-tidal-volume ventilation with PEEP vs no ventilation during CPB
  • VENTn = 352
  • No-ventilation (noV)n = 373reference
Primary endpoint
Composite of:
  • Death
  • Early respiratory failure
  • Ventilation support beyond day 2
  • Reintubation
Methodological detailspost-hoc analysis, single-centre, blind, parallel-group
  • Post-hoc analysis
  • Single-centre
  • Blind
  • Parallel-group

Primary result

As reported in the abstract

Odds ratio

0.56

CI 0.37–0.84

P = 0.004

Events by treatment group

VENT vs noV
OR 0.56 (CI 0.37–0.84); P = 0.004

Further findings

OutcomeOR (CI)P value
Early respiratory dysfunction0.34 (0.12–0.96)P = 0.033
Prolonged respiratory support0.51 (0.27–0.94)P = 0.029

Safety

Complications related to mechanical ventilation

Similar in the two groups

Original publication

Efficacy of maintaining low-tidal volume mechanical ventilation as compared to resting lung strategy during coronary artery bypass graft cardiopulmonary bypass surgery: A post-hoc analysis of the MECANO trial. J Clin Anesth. Published 5 November 2022. doi:10.1016/j.jclinane.2022.110991

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.